Evidence map›Paper›PMID 41697470›Full record

ArticleAnnals of surgical oncology2026

Refining Postoperative Radiotherapy in Early-Stage Oral Squamous Cell Carcinoma: Impact of Perineural and Lymphovascular Invasion.

Tung-Yun Huang, Li-Jen Liao, Yu-Ping Cheng, Wan-Lun Hsu, Chun-Ju Chiang, Chun-Wei Chang, Wen-Chung Lee, Cheng-Ping Wang, Pei-Jen Lou, Yih-Leong Chang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tung-Yun Huang *Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Li-Jen Liao *Department of Otolaryngology Head and Neck Surgery, Far Eastern Memorial Hospital, New Taipei, Taiwan.
Yu-Ping ChengData Science Center, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Wan-Lun HsuData Science Center, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Chun-Ju ChiangGraduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Chun-Wei ChangDepartment of Otolaryngology, National Taiwan University BioMedical Park Hospital, Hsin-Chu, Taiwan.
Wen-Chung LeeGraduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Cheng-Ping WangDepartment of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Pei-Jen LouDepartment of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Yih-Leong ChangDepartment of Pathology, National Taiwan University Cancer Center and National University College of Medicine, Taipei, Taiwan.
Tseng-Cheng ChenDepartment of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. kmu8501094@yahoo.com.tw.

Funding

Health Promotion Administration, Ministry of Health and Welfare A1121004National Taiwan University Cancer Center NTUCCS-114-04National Taiwan University Hospital Joint Research Programs 113-FTN0015Taiwan National Science and Technology Council 112-2314-B-002-091-MY3
6 · The paper itself

Abstract

backgroundThe prognostic significance of perineural invasion (PNI) and lymphovascular invasion (LVI) in early-stage oral squamous cell carcinoma (OSCC) remains uncertain. The role of postoperative radiotherapy (PORT) in this subgroup is debated. This study aimed to clarify the clinical impact of PNI/LVI and determine the effect of PORT across risk-stratified subsets of early-stage OSCC.

methodsWe retrospectively analyzed 6,121 patients with pT1-2N0M0 OSCC from the Taiwan Cancer Registry (2018-2022). Patients were categorized into Group A (PNI-/LVI-) and Group B (PNI+ and/or LVI+). Clinicopathological characteristics, survival outcomes, and the effect of PORT were assessed using multivariable analysis and propensity score matching (PSM).

resultsThe PNI/LVI positivity occurred in 13.5% of patients and was independently associated with poorer differentiation, greater depth of invasion (> 5 mm), T2 classification, tongue subsite, lower BMI, and female sex. Group B patients exhibited significantly lower overall survival (HR 1.45, p = 0.001) and disease-free survival (HR 1.44, p < 0.001), with inferior locoregional control versus Group A. PORT significantly improved locoregional control in Group B (p = 0.005), but no overall or disease-free survival benefit was observed, likely due to effective salvage surgery. In contrast, in Group A, PORT offered no benefit and was associated with worse outcomes.

conclusionsPerineural invasion and/or LVI represent key adverse prognosticators in early-stage OSCC. Postoperative radiotherapy selectively enhances locoregional control in intermediate-risk patients, but survival outcomes remain unaffected. A risk-adapted therapeutic approach is warranted, tailoring PORT to patients with adverse features and avoiding overtreatment in low-risk cases.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsPeripheral NervesSquamous Cell Carcinoma of Head and NeckAgedFemaleFollow-Up StudiesHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingPrognosisRadiotherapy, AdjuvantRetrospective StudiesDisease control and survivalsEarly stageLocoregional recurrenceLymphovascular invasionOral squamous cell carcinomaPerineural invasionPostoperative adjuvant radiotherapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.